Published in Medical Devices and Surgical Technology Week, February 5th, 2006
In a recent study, researchers in Brazil sought to characterize CS-FTL results "in normal individuals and to establish reference levels for discrimination of normal individuals and patients with systemic sclerosis (SSc)."
"FTL was determined before (pre-CS) and 3, 8, and 13 min after cold stimulus (post-CS) in 94 normal controls according to gender and age," explained C. Kayser and coauthors at the Federal University of Sao Paulo. "Diagnostic performance of Delta CS-FTL (percentage difference between post- and pre-CS-FTL) was tested...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.